OHSU

Past Speakers - Riker Lecture

Date Speaker Topic
February 11, 2010
Larry Marnett, Ph.D.
Mary Geddes Stahlman Professor of Cancer Research; Professor of Biochemistry;Professor of Chemistry
Vanderbilt University


January 15, 2009
Allan Rettie, Ph.D.
Professor and Chair, Department of Medicinal Chemistry
University of Washington

"Warfarin Pharmacogenomics: A Model for Personalized Medicine"
January 30, 2008 David Colquhoun, Ph.D.
Department of Pharmacology
University College London
On the nature of partial agonism: single channels allow a new way of looking at an old problem
January 24, 2007 Dr. Garret A. FitzGerald, M.D.
Chair, Department of Pharmacology
Director, Center for Experimental Therapeutics & Clinical Research Center
Director, Institute for Translational Medicine & Therapeutics
University of Pennsylvania, Philadelphia, PA
Cyclooxygenases: Their Products and Inhibitors
February 1, 2006 Bert W. O'Malley, M.D.
Tom Thompson Professor and Chair, Department of Molecular and Cellular Biology
Director, Baylor Center for Reproductive Biology
Baylor College of Medicine, Houston, TX
The Biological and Medical Implications of Steroid Receptor Coactivators
February 2, 2005 Bradley J. Undem, Ph.D.
Professor of Medicine
Department of Medicine at John Hopkins University
Pharmacology of Vagal Sensory Nerve Activation
February 18, 2004 D. James Surmeier, Jr., Ph.D.
Professor and Chair, Department of Physiology
Northwestern University Medical School, Chicago, IL
The Mystery of Postsynaptic D2 Receptor Signaling in the Striatum
January 15, 2003 Darrell R. Abernethy, M.D., Ph.D.
Chief, Laboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health Professor of Medicine and Pharmacology and Molecular Science, John Hopkins Univ. School of Medicine
Structural Diversity of the L-Type Calcium Channel: Relating Structure to Function for Pharmacology and Physiology
February 20, 2002 Brian Druker, M.D.
Director of the Leukemia Center
Oregon Cancer Institute, OHSU
Targeted Cancer Therapies: Lessons Learned from ST1571 and Chronic Mylogenous Leukemia
June 6, 2001 Ronald Evans, Ph.D.
March of Dimes Chair in Developmental and Molecular Biology and Professor in the Gene Expression Laboratory
The Salk Institute for Biological Studies
Investigator, Howard Hughes Medical Institute
Nuclear Receptors, SXR and the Xenobiotic Response
January 19, 2000 Robert Freedman, M.D.
Human Medical Genetics Program
University of Colorado Health Sciences Center
Nicotinic Receptors in Schizophrenia
January 28, 1999 Frances M. Leslie, Ph.D.
Professor, Department of Pharmacology and Anatomy and Neurobiology
Director, Transdisciplinary Tobacco Use Research Center
University of California, Irvine
The Influence of Nicotine on Brain Development
January 21, 1998 Barry J. Hoffer, M.D., Ph.D.
Chief, Cellular Neurophysiology Section, Intramural Research Section, National Institute on Drug Abuse
Glial Cell Line-Derived Neurotrophic Factor and Dopamine Neurons
October 23, 1996 Hazel Hon Szeto, M.D., Ph.D.
Professor of Pharmacology
Weill Cornell Medical College,
Cornell University
Mechanisms of Dynorphin-Mediated Release of Adrenocorticotrophin
September 14, 1995 Raymond L. Woosley, M.D., Ph.D.
Professor and Chair, Department of Pharmacology
Georgetown University School of Medicine
Prescriptions, Pills and Blind Faith
April 28, 1994 V. Craig Jordan, Ph.D., D.Sc
Professor of Cancer Pharmacology
Director, Breast Cancer Research Program, Robert H. Lurie Comprehensive Cancer Center
Northwestern University Medical School
Antiestrogens: Targeted Tools in Molecular Biology and Therapeutic Applications for Breast Cancer, Coronary Heart Disease and Osteoporosis
May 13, 1993 F. Peter Guengerich, Ph.D.
Professor of Biochemistry
Director, Center in Molecular Toxicity
Vanderbilt University School of Medicine
Human Cytochrome p450 Enzymes: Characterization, Properties and Relevance to Drug Metabolism and Efficacy
May 21, 1992 R. Alan North, M.D., Ph.D. Potassium Channels: The First 50 Years and the Last 5 Months
May 23, 1991 William W. Fleming, Ph.D.
Professor of Pharmacology
West Virginia University School of Medicine
Adaptation of Myenteric Neurons to Chronic Exposure to Morphine
April 26, 1990 Elliot S. Vesell, M.D.
Professor and Chair, Department of Pharmacology
Pennsylvania State University College of Medicine
Causes and Consequences of Variations in Drug Response
April 13, 1989 Sydney Spector, Ph.D.
Professor of Psychiatry and Pharmacology
Vanderbilt University School of Medicine
Presence of Endogenous Opiate Alkaloids in Mammalian Tissues
May 19, 1988 Joseph Larner, M.D., Ph.D.
Professor and Chair, Department of Pharmacology
University of Virginia
Insulin Signaling Mechanisms: Altered Polypeptide Phosphorylation and Mediator Production
May 21, 1987 Robert F. Furchgott, Ph.D.
Professor Emeritus of Pharmacology
SUNY Health Science Center, Brooklyn, NY
Endothelium-Dependent Vasodilation and the Endothelium-Derived Relaxing Factor
May 15, 1986 Philip Needleman, Ph.D.
Professor and Chair, Department of Pharmacology
Washington University School of Medicine
Atriopeptins: Cardiac Hormones Involved in Fluid, Electrolyte, and Blood Pressure Regulation
October 11, 1984 Paul Calabresi, M.D.
Professor and Chair, Department of Medicine, Brown University
Director, Brown University Cancer Center
Cancer: Crab or Chimera? The Clinical Implications of Cancer Cell Heterogeneity
May 19, 1983 Avram Goldstein, M.D.
Professor of Pharmacology
Director, Addiction Research Foundation
Stanford University
The Dynorphin Peptins and the Kappa Opioid Receptor
May 12, 1982 Walter F. Riker, Jr., M.D.
Professor and Chair, Department of Pharmacology
Weill Medical College, Cornell University
Reflections on Pharmacologic and Other Effects of Curare